Evidence map›Paper›PMID 38298710›Full record

ArticleHeliyon2024

Upcycling waste derived glass into high-performance photocatalytic scaffolds by alkali activation and direct ink writing.

Mokhtar Mahmoud, Jozef Kraxner, Akansha Mehta, Hamada Elsayed, Dušan Galusek, Enrico Bernardo

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Mokhtar MahmoudFunGlass, Alexander Dubček University of Trenčín, Trenčín, Slovakia.
Jozef KraxnerFunGlass, Alexander Dubček University of Trenčín, Trenčín, Slovakia.
Akansha MehtaFunGlass, Alexander Dubček University of Trenčín, Trenčín, Slovakia.
Hamada ElsayedDepartment of Industrial Engineering, University of Padova, Padova, Italy.
Dušan GalusekFunGlass, Alexander Dubček University of Trenčín, Trenčín, Slovakia.
Enrico BernardoDepartment of Industrial Engineering, University of Padova, Padova, Italy.
Trencianska Univerzita Alexandra Dubceka V Trencine · SKUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel and eco-friendly solutions are extensively needed for wastewater treatment. This work capitalizes on the combination of waste vitrification and additive manufacturing to produce an efficient photocatalyst for the specific purpose. Fine powders of waste-derived glass, containing Fe3O4 inclusions, by simple suspension (for a solid loading of 65 wt %) in alkaline solution (5 M NaOH), were transformed into pastes for direct ink writing. 3D-printed reticulated scaffolds were stabilized by the progressive hardening of a zeolite-like gel, formed by glass/solution interaction, at nearly room temperature. The printed scaffolds were successfully tested for the removal of methylene blue, realized by combining the high sorption capacity of the gel with the catalytic activity of magnetite inclusions, under UV light. A complete degradation of methylene blue is achieved by 90 min exposure, comparing favorably with other reported photocatalytic materials, requiring from 60 to 360 min. The photocatalytic activity was tested for several cycles, with no significant degradation. In other words, a waste-derived material can be reused for multiple times, to remediate wastewaters, with evident benefits on waste minimization.

Indexed as

Additive manufacturingAlkali activationDirect ink writingMethylene bluePhotocatalystVitrification

Identifiers

PMID38298710
PMCPMC10828805
OpenAlexW4390948617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.